175 results
S-8
EX-4.4
oy0bqc7m2cjqni
22 Feb 24
Registration of securities for employees
5:50pm
S-8
EX-4.5
tau5q4brfdfkzry34
22 Feb 24
Registration of securities for employees
5:50pm
8-K
EX-99.2
s1dnpm2gby ht
30 Nov 23
AbbVie to Acquire ImmunoGen, including its Flagship Cancer Therapy ELAHERE® (mirvetuximab soravtansine-gynx), Expanding Solid Tumor Portfolio
8:47am
8-K
EX-99.1
6z472lnt9tx b2
30 Nov 23
AbbVie to Acquire ImmunoGen, including its Flagship Cancer Therapy ELAHERE® (mirvetuximab soravtansine-gynx), Expanding Solid Tumor Portfolio
8:47am
11-K
pzlg1n
28 Jun 23
Annual report of employee stock purchases
5:00pm